APLS icon

Apellis Pharmaceuticals

243 hedge funds and large institutions have $5.19B invested in Apellis Pharmaceuticals in 2022 Q4 according to their latest regulatory filings, with 36 funds opening new positions, 96 increasing their positions, 83 reducing their positions, and 40 closing their positions.

Holders
243
Holders Change
-6
Holders Change %
-2.41%
% of All Funds
3.92%
Holding in Top 10
12
Holding in Top 10 Change
+2
Holding in Top 10 Change %
+20%
% of All Funds
0.19%
New
36
Increased
96
Reduced
83
Closed
40
Calls
$81.6M
Puts
$55.8M
Net Calls
+$25.8M
Net Calls Change
+$45.2M
Name Market Value Shares Shares
Change
Shares
Change %
AIM
276
Aigen Investment Management
New York
-3,438 Closed
Franklin Resources
277
Franklin Resources
California
-3,337 Closed
GT
278
Glenmede Trust
Pennsylvania
-3,157 Closed
CAM
279
Cresset Asset Management
Illinois
-3,000 Closed
CMP
280
Coston McIsaac & Partners
Maine
-2,000 Closed
PHK
281
Point72 Hong Kong
Hong Kong
-950 Closed
DFCM
282
Dark Forest Capital Management
Puerto Rico
-519 Closed
CAL
283
Capital Advisors Ltd
Ohio
$0 8 -3 -27%
Walleye Capital
284
Walleye Capital
New York
CL
285
CSS LLC
Illinois
BFM
286
Boothbay Fund Management
New York
Belvedere Trading
287
Belvedere Trading
Illinois
PVI
288
Pura Vida Investments
New York
SSG
289
Summit Securities Group
New York
HT
290
HAP Trading
New York
WVP
291
Worth Venture Partners
New Jersey
SFM
292
Sphera Funds Management
Israel
JGC
293
J. Goldman & Co
New York
SCM
294
Sio Capital Management
New York
Walleye Trading
295
Walleye Trading
New York
CFGS
296
Concourse Financial Group Securities
Alabama
PI
297
PEAK6 Investments
Illinois
KCM
298
Kingdon Capital Management
New York
Nomura Asset Management
299
Nomura Asset Management
Japan